Invest in

Fighting Fat

7.8%
2.8%
0.0%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
7.8%
2.8%
0.0%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
52.0% Diabetes Care 6.2%
17.3% Merck & Company Inc. (new) MRK 16.1%
14.9% Sanofi American Depositary Shares (Each repstg one-half of one) SNY 1.2%
13.0% Novo Nordisk A/S NVO 36.6%
2.6% Astrazeneca Plc ADR AZN 19.4%
2.5% Alkermes plc ALKS 24.5%
1.8% Integer Holdings Corporation ITGR --
41.9% Weight Management 37.7%
20.1% NutriSystem Inc NTRI 72.2%
9.2% MEDIFAST INC MED 38.5%
3.8% Weight Watchers International Inc WTW 56.6%
3.5% Nu Skin Enterprises Inc. (A) NUS 33.0%
2.1% USANA Health Sciences Inc. USNA 10.6%
1.8% Vitamin Shoppe Inc VSI 20.5%
1.3% GNC Holdings Inc. Class A GNC 53.5%
6.1% Weight Loss Drugs 26.7%
6.1% Arena Pharmaceuticals Inc. ARNA 26.7%

Quotes delayed 15 mins. Currently Dec 9, 2016 6:33:17 AM. Fields are marked with -- when data is unavailable.